The DOI matches its Crossref record; 317 of the 317 references it cites were found in a registry or an index.
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Open accessAbstract
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,596
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Zimmerli, W., Trampuz, A., & Ochsner, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040181 · Cited by 3,116
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Self-citationRybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationNaimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Self-citationCommunity-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Self-citationMethicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Self-citationDaptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Self-citationHerold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus
Bode, L. G. M., Kluytmans, J. A. J. W., Wertheim, H. F. L., Bogaers, D., Vandenbroucke-Grauls, C. M. J. E., Roosendaal, R., Troelstra, A., Box, A. T. A., Voss, A., van der Tweel, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0808939 · Cited by 1,219
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Self-citationZimmerli, W. (1998) · JAMA · doi:10.1001/jama.279.19.1537 · Cited by 1,079
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Self-citationBaddour, L. M., Epstein, A. E., Erickson, C. C., Knight, B. P., Levison, M. E., Lockhart, P. B., Masoudi, F. A., Okum, E. J., Wilson, W. R., Beerman, L. B., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192665 · Cited by 1,030
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
Rybak, M. J., Lomaestro, B. M., Rotscahfer, J. C., Moellering, R. C., Craig, W. A., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · Clinical Infectious Diseases · doi:10.1086/600877 · Cited by 815
Self-citationClinical Practice Guidelines: Directions for a New Program
Committee to Advise the Public Health Service on Clinical Practice Guidelines, & Institute of Medicine (1990) · National Academies Press eBooks · doi:10.17226/1626 · Cited by 803
Soriano, A., Marco, F., Martinez, J. A., Pisos, E., Almela, M., Dimova, V. P., Alamo, D., Ortega, M., Lopez, J., & Mensa, J. (2008) · Clinical Infectious Diseases · doi:10.1086/524667 · Cited by 767
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
A Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Francis, J. S., Doherty, M. C., Lopatin, U., Johnston, C. P., Sinha, G., Ross, T., Cai, M., Hansel, N. N., Perl, T., Ticehurst, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427148 · Cited by 719
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Three-Year Surveillance of Community-AcquiredStaphylococcus aureus Infections in Children
Kaplan, S. L., Hulten, K. G., Gonzalez, B. E., Hammerman, W. A., Lamberth, L., Versalovic, J., & Mason, E. O. (2005) · Clinical Infectious Diseases · doi:10.1086/430312 · Cited by 602
Self-citationLevine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Self-citationLodise, T. P., Lomaestro, B., Graves, J., & Drusano, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01602-07 · Cited by 574
Wunderink, R. G., Rello, J., Cammarata, S., et al. (2003) · PubMed · Cited by 566
Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M., & Stellrecht, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-08 · Cited by 553
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
Silverman, J. A., Mortin, L. I., VanPraagh, A. D. G., Li, T., & Alder, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/430352 · Cited by 541
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Tenover, F. C., McDougal, L. K., Goering, R. V., Killgore, G., Projan, S. J., Patel, J. B., & Dunman, P. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.1.108-118.2006 · Cited by 524
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
Strategies to Prevent Surgical Site Infections in Acute Care Hospitals
Anderson, D. J., Kaye, K. S., Classen, D., Arias, K. M., Podgorny, K., Burstin, H., Calfee, D. P., Coffin, S. E., Dubberke, E. R., Fraser, V., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591064 · Cited by 478
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., & Knirsch, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2260-2266.2005 · Cited by 457
Linezolid: The First Oxazolidinone Antimicrobial
Moellering, R. C. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00015 · Cited by 455
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Tenover, F. C., & Moellering, R. C. (2007) · Clinical Infectious Diseases · doi:10.1086/513203 · Cited by 452
Stevens, D. L., Ma, Y., Salmi, D. B., McIndoo, E., Wallace, R. J., & Bryant, A. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/510396 · Cited by 452
Pallin, D. J., Egan, D. J., Pelletier, A. J., Espinola, J. A., Hooper, D. C., & Camargo, C. A. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.12.004 · Cited by 447
Fowler, V. G., Sanders, L. L., Sexton, D. J., Kong, L., Marr, K. A., Gopal, A. K., Gottlieb, G., McClelland, R. S., & Corey, G. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514686 · Cited by 441
Rubinstein, E., Cammarata, S. K., Oliphant, T. H., Wunderink, R. G., & the Linezolid Nosocomial Pneumonia Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/318486 · Cited by 440
Nosocomial Bacterial Meningitis
van de Beek, D., Drake, J. M., & Tunkel, A. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0804573 · Cited by 433
Rybak, M. J., Abate, B. J., Kang, S. L., Ruffing, M. J., Lerner, S. A., & Drusano, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1549 · Cited by 431
Self-citationCui, L., Tominaga, E., Neoh, H.-M., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1079-1082.2006 · Cited by 427
Fowler, V. G., Li, J., Corey, G. R., Boley, J., Marr, K. A., Gopal, A. K., Kong, L. K., Gottlieb, G., Donovan, C. L., Sexton, D. J., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00250-7 · Cited by 423
Steinkraus, G., White, R., & Friedrich, L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm258 · Cited by 420
Mart??nez-Aguilar, G., Avalos-Mishaan, A., Hulten, K., Hammerman, W., Mason, E. O., & Kaplan, S. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133044.79130.2a · Cited by 416
Self-citationWootton, M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.399 · Cited by 414
Ellis‐Grosse, E. J., Babinchak, T., Dartois, N., Rose, G., Loh, E., & Groups, T. 3. A. 3. C. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431675 · Cited by 414
Rybak, M. J., Lomaestro, B. M., Rotschafer, J. C., Moellering, R. C., Craig, W. A., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.11.1275 · Cited by 403
Self-citationVancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Self-citationSwartz, M. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp031807 · Cited by 396
KARCHMER, A. W., ARCHER, G. L., & DISMUKES, W. E. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-4-447 · Cited by 395
Self-citationLEE, M. C., RIOS, A. M., ATEN, M. F., MEJIAS, A., CAVUOTI, D., MCCRACKEN, G. H., & HARDY, R. D. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000109288.06912.21 · Cited by 394
Diep, B. A., Chambers, H. F., Graber, C. J., Szumowski, J. D., Miller, L. G., Han, L. L., Chen, J. H., Lin, F., Lin, J., Phan, T. H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00204 · Cited by 391
Self-citationCharles, P. G. P., Ward, P. B., Johnson, P. D. R., Howden, B. P., & Grayson, M. L. (2004) · Clinical Infectious Diseases · doi:10.1086/381093 · Cited by 384
Severe Community-acquired Pneumonia Due to Staphylococcus aureus , 2003–04 Influenza Season
Hageman, J. C., Uyeki, T. M., Francis, J. S., Jernigan, D. B., Wheeler, J. G., Bridges, C. B., Barenkamp, S. J., Sievert, D. M., Srinivasan, A., Doherty, M. C., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051141 · Cited by 379
Wang, G., Hindler, J. F., Ward, K. W., & Bruckner, D. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01388-06 · Cited by 358
Arnold, S. R., Elias, D., Buckingham, S. C., Thomas, E. D., Novais, E., Arkader, A., & Howard, C. (2006) · Journal of Pediatric Orthopaedics · doi:10.1097/01.bpo.0000242431.91489.b4 · Cited by 358
Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510386 · Cited by 348
Fridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M., Tenover, F. C., & the Vancomycin‐Intermediate Staphylococcus aureus Epidemiology Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/346207 · Cited by 344
Self-citationMarkowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Septic Thrombosis of the Dural Venous Sinuses
SOUTHWICK, F. S., RICHARDOSON, E. P., & SWARTZ, M. N. (1986) · Medicine · doi:10.1097/00005792-198603000-00002 · Cited by 337
Vikram, H. R., Buenconsejo, J., Hasbun, R., & Quagliarello, V. J. (2003) · JAMA · doi:10.1001/jama.290.24.3207 · Cited by 335
Miro, J. M., Anguera, I., Cabell, C. H., Chen, A. Y., Stafford, J. A., Corey, G. R., Olaison, L., Eykyn, S., Hoen, B., Abrutyn, E., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/431979 · Cited by 334
Self-citationJeffres, M. N., Isakow, W., Doherty, J. A., Micek, S. T., & Kollef, M. H. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.06.014 · Cited by 334
Moise-Broder, P. A., Sakoulas, G., Eliopoulos, G. M., Schentag, J. J., Forrest, A., & Moellering, R. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421092 · Cited by 332
Linezolid: The First Oxazolidinone Antimicrobial
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00017 · Cited by 328
Trends in US Hospital Admissions for Skin and Soft Tissue Infections
Edelsberg, J., Taneja, C., Zervos, M., Haque, N., Moore, C., Reyes, K., Spalding, J., Jiang, J., & Oster, G. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.081228 · Cited by 326
Liu, C., & Chambers, H. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3040-3045.2003 · Cited by 321
Self-citationBenvenuto, M., Benziger, D. P., Yankelev, S., & Vigliani, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-06 · Cited by 319
Walsh, T. R., Bolmström, A., Qwärnström, A., Ho, P., Wootton, M., Howe, R. A., MacGowan, A. P., & Diekema, D. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2439-2444.2001 · Cited by 319
Miller, L. G., & Diep, B. A. (2008) · Clinical Infectious Diseases · doi:10.1086/526773 · Cited by 318
Wunderink, R. G., Rello, J., Cammarata, S. K., Croos-Dabrera, R. V., & Kollef, M. H. (2003) · Chest · doi:10.1016/s0012-3692(15)33412-7 · Cited by 317
MARTÍNEZ-AGUILAR, G., HAMMERMAN, W. A., MASON, E. O., & KAPLAN, S. L. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073163.37519.ee · Cited by 315
Self-citationWidmer, A. F., Frei, R., Rajacic, Z., & Zimmerli, W. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.96 · Cited by 315
Lewis, J. S., & Jorgensen, J. H. (2005) · Clinical Infectious Diseases · doi:10.1086/426894 · Cited by 313
Finelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D. K., Kamimoto, L., Fry, A., Hageman, J., Gorwitz, R., Bresee, J., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1336 · Cited by 312
Self-citationPatel, J. B., Gorwitz, R. J., & Jernigan, J. A. (2009) · Clinical Infectious Diseases · doi:10.1086/605495 · Cited by 312
Self-citationInitial Low‐Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Cosgrove, S. E., Vigliani, G. A., Campion, M., Fowler, Jr., Abrutyn, E., Corey, G. R., Levine, D. P., Rupp, M. E., Chambers, H. F., Karchmer, A. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597031 · Cited by 309
Self-citationSerum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Rodvold, K. A., Gotfried, M. H., Cwik, M., Korth-Bradley, J. M., Dukart, G., & Ellis-Grosse, E. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl403 · Cited by 304
Kim, S.-H., Kim, K.-H., Kim, H.-B., Kim, N.-J., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-07 · Cited by 300
Systematic review and meta-analysis of antibiotic therapy for bone and joint infections
Stengel, D., Bauwens, K., Sehouli, J., Ekkernkamp, A., & Porzsolt, F. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00094-9 · Cited by 299
Noskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J., Hedblom, E. C., Smulders, M., Lapetina, E., & Gemmen, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1756 · Cited by 299
Lamer, C., de Beco, V, Soler, P., Calvat, S., Fagon, J. Y., Dombret, M. C., Farinotti, R., Chastre, J., & Gibert, C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.281 · Cited by 297
Chamis, A. L., Peterson, G. E., Cabell, C. H., Corey, G. R., Sorrentino, R. A., Greenfield, R. A., Ryan, T., Reller, L. B., & Fowler, V. G. (2001) · Circulation · doi:10.1161/hc3401.095097 · Cited by 292
Heldman, A. W., Hartert, T. V., Ray, S. C., Daoud, E. G., Kowalski, T. E., Pompili, V. J., Sisson, S. D., Tidmore, W. C., vom Eigen, K. A., Goodman, S. N., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00070-8 · Cited by 289
Stryjewski, M. E., Graham, D. R., Wilson, S. E., O’Riordan, W., Young, D., Lentnek, A., Ross, D. P., Fowler, V. G., Hopkins, A., Friedland, H. D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587896 · Cited by 289
Simor, A. E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H. R., & Kiss, A. (2007) · Clinical Infectious Diseases · doi:10.1086/510392 · Cited by 286
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers
van Rijen, M., Bonten, M., Wenzel, R., & Kluytmans, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006216.pub2 · Cited by 286
Harbarth, S., Dharan, S., Liassine, N., Herrault, P., Auckenthaler, R., & Pittet, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1412 · Cited by 286
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284
Self-citationGonzalez, B. E., Hulten, K. G., Dishop, M. K., Lamberth, L. B., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2005) · Clinical Infectious Diseases · doi:10.1086/432475 · Cited by 282
Self-citationStaphylococcus aureus Sepsis and the Waterhouse–Friderichsen Syndrome in Children
Adem, P. V., Montgomery, C. P., Husain, A. N., Koogler, T. K., Arangelovich, V., Humilier, M., Boyle-Vavra, S., & Daum, R. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044194 · Cited by 279
Self-citationClindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
FRANK, A. L., MARCINAK, J. F., MANGAT, P. D., TJHIO, J. T., KELKAR, S., SCHRECKENBERGER, P. C., & QUINN, J. P. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200206000-00010 · Cited by 271
Sánchez García, M. (2010) · JAMA · doi:10.1001/jama.2010.757 · Cited by 270
Antibiotic treatment of Gram-positive bone and joint infections
Darley, E. S. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh191 · Cited by 266
Penetration of vancomycin into human lung tissue
Cruciani, M., Gatti, G., Lazzarini, L., Furlan, G., Broccali, G., Malena, M., Franchini, C., & Concia, E. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.865 · Cited by 264
Changing patterns in acute hematogenous osteomyelitis and septic arthritis
Schmale, G. A. (2007) · Clinical Orthopaedics and Related Research · Cited by 264
Sakoulas, G., Alder, J., Thauvin-Eliopoulos, C., Moellering, R. C., & Eliopoulos, G. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1581-1585.2006 · Cited by 262
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock*
Kreymann, K. G., de Heer, G., Nierhaus, A., & Kluge, S. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000295263.12774.97 · Cited by 258
Jones, R. N. (2006) · Clinical Infectious Diseases · doi:10.1086/491710 · Cited by 254
Peripheral neuropathy associated with prolonged use of linezolid
Bressler, A. M., Zimmer, S. M., Gilmore, J. L., & Somani, J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01109-0 · Cited by 246
Pannaraj, P. S., Hulten, K. G., Gonzalez, B. E., Mason, Jr., & Kaplan, S. L. (2006) · Clinical Infectious Diseases · doi:10.1086/507637 · Cited by 242
Self-citationDevelopment of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Comparison of Short-Course (5 Days) and Standard (10 Days) Treatment for Uncomplicated Cellulitis
Hepburn, M. J., Dooley, D. P., Skidmore, P. J., Ellis, M. W., Starnes, W. F., & Hasewinkle, W. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1669 · Cited by 240
Wunderink, R. G., Cammarata, S. K., Oliphant, T. H., & Kollef, M. H. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80118-2 · Cited by 229
Gorwitz, R. J., Jernigan, D. B., Powers, J. H., & Jernigan, J. A. (2006) · Cited by 226
Self-citationVenous Thrombosis Associated With Staphylococcal Osteomyelitis in Children
Gonzalez, B. E., Teruya, J., Mahoney, D. H., Hulten, K. G., Edwards, R., Lamberth, L. B., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2006) · Pediatrics · doi:10.1542/peds.2005-2009 · Cited by 225
Self-citationBozdogan, B. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg457 · Cited by 225
Purpura Fulminans Due to Staphylococcus aureus
Kravitz, G. R., Dries, D. J., Peterson, M. L., & Schlievert, P. M. (2005) · Clinical Infectious Diseases · doi:10.1086/428573 · Cited by 224
Peltola, H., Pääkkönen, M., Kallio, P., Kallio, M. J. T., & Osteomyelitis–Septic Arthritis (OM‐SA) Study Group (2009) · Clinical Infectious Diseases · doi:10.1086/597582 · Cited by 223
Nahum, G. G., Uhl, K., & Kennedy, D. L. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000216197.26783.b5 · Cited by 221
Laupland, K. B., Kirkpatrick, A. W., & Delaney, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000295312.13466.1c · Cited by 220
Jeffres, M. N., Isakow, W., Doherty, J. A., McKinnon, P. S., Ritchie, D. J., Micek, S. T., & Kollef, M. H. (2006) · Chest · doi:10.1378/chest.130.4.947 · Cited by 219
D’Agata, E. M. C., Webb, G. F., Horn, M. A., Moellering, Jr., & Ruan, S. (2009) · Clinical Infectious Diseases · doi:10.1086/595844 · Cited by 218
Rajendran, P. M., Young, D., Maurer, T., Chambers, H., Perdreau-Remington, F., Ro, P., & Harris, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00377-07 · Cited by 214
Self-citationRuhe, J. J., Smith, N., Bradsher, R. W., & Menon, A. (2007) · Clinical Infectious Diseases · doi:10.1086/511872 · Cited by 214
The Management and Outcome of Spinal Implant Infections: Contemporary Retrospective Cohort Study
Kowalski, T. J., Berbari, E. F., Huddleston, P. M., Steckelberg, J. M., Mandrekar, J. N., & Osmon, D. R. (2007) · Clinical Infectious Diseases · doi:10.1086/512194 · Cited by 214
Perlroth, J., Kuo, M., Tan, J., Bayer, A. S., & Miller, L. G. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.805 · Cited by 212
Self-citationSubinhibitory Concentrations of Linezolid Reduce Staphylococcus aureus Virulence Factor Expression
Bernardo, K., Pakulat, N., Fleer, S., Schnaith, A., Utermöhlen, O., Krut, O., Müller, S., & Krönke, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.546-555.2004 · Cited by 211
Duong, M., Markwell, S., Peter, J., & Barenkamp, S. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.03.014 · Cited by 210
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy
Tice, A. D., Hoaglund, P. A., & Shoultz, D. A. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00231-6 · Cited by 209
Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205
Self-citationSeptic arthritis: current diagnostic and therapeutic algorithm
Mathews, C. J., & Coakley, G. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283036975 · Cited by 201
MRSA outbreak was controlled with daily hexachlorophene showers and hygiene education.
Nguyen, D. M., Mascola, L., & Bancroft, E. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1104.041094 · Cited by 199
Marty, F. M., Yeh, W. W., Wennersten, C. B., Venkataraman, L., Albano, E., Alyea, E. P., Gold, H. S., Baden, L. R., & Pillai, S. K. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.595-597.2006 · Cited by 199
Reynolds, H. R., Jagen, M. A., Tunick, P. A., & Kronzon, I. (2003) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2003.43 · Cited by 198
Linezolid Resistance inStaphylococcus aureus:Characterization and Stability of Resistant Phenotype
Pillai, S. K., Sakoulas, G., Wennersten, C. B., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/345368 · Cited by 193
(1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.5.959 · Cited by 192
Breedt, J., Teras, J., Gardovskis, J., Maritz, F. J., Vaasna, T., Ross, D. P., Gioud-Paquet, M., Dartois, N., Ellis-Grosse, E. J., & Loh, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4658-4666.2005 · Cited by 192
Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization
Loeb, M. B., Main, C., Eady, A., & Walkers-Dilks, C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003340 · Cited by 189
Climo, M. W., Patron, R. L., & Archer, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1747 · Cited by 189
Conservative Treatment of Staphylococcal Prosthetic Joint Infections in Elderly Patients
Barberán, J., Aguilar, L., Carroquino, G., Giménez, M.-J., Sánchez, B., Martínez, D., & Prieto, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.036 · Cited by 187
Szumowski, J., Cohen, D., Kanaya, F., & Mayer, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01244-06 · Cited by 185
Mohr, J. F., & Murray, B. E. (2007) · Clinical Infectious Diseases · doi:10.1086/518451 · Cited by 185
Self-citationYang, E. S., Tan, J., Eells, S., Rieg, G., Tagudar, G., & Miller, L. G. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02836.x · Cited by 183
Patel, J. B., Jevitt, L. A., Hageman, J., McDonald, L. C., & Tenover, F. C. (2006) · Clinical Infectious Diseases · doi:10.1086/504084 · Cited by 183
Calfee, D. P., Salgado, C. D., Classen, D., Arias, K. M., Podgorny, K., Anderson, D. J., Burstin, H., Coffin, S. E., Dubberke, E. R., Fraser, V., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591061 · Cited by 182
Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis
Turgeon, A. F., Hutton, B., Fergusson, D. A., McIntyre, L., Tinmouth, A. A., Cameron, D. W., & Hébert, P. C. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-3-200702060-00009 · Cited by 179
Limitations of Vancomycin in the Management of Resistant Staphylococcal Infections
Kollef, M. H. (2007) · Clinical Infectious Diseases · doi:10.1086/519470 · Cited by 178
Micek, S. T., Dunne, M., & Kollef, M. H. (2005) · Chest · doi:10.1378/chest.128.4.2732 · Cited by 178
Lipsky, B. A., & Stoutenburgh, U. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh531 · Cited by 176
Perspectives on Daptomycin Resistance, with Emphasis on Resistance in Staphylococcus aureus
Boucher, H. W., & Sakoulas, G. (2007) · Clinical Infectious Diseases · doi:10.1086/520655 · Cited by 174
Purcell, K., & Fergie, J. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.10.980 · Cited by 173
Counterpoint: Vancomycin and Staphylococcus aureus--An Antibiotic Enters Obsolescence
Deresinski, S. (2007) · Clinical Infectious Diseases · doi:10.1086/518452 · Cited by 173
Dworkin, R. J., Sande, M. A., Lee, B. L., & Chambers, H. F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91083-0 · Cited by 170
Self-citationLaupland, K. B., & Conly, J. M. (2003) · Clinical Infectious Diseases · doi:10.1086/377735 · Cited by 169
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl219 · Cited by 167
Treatment Failure Resulting from Resistance of Staphylococcus aureus to Daptomycin
Skiest, D. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.655-656.2006 · Cited by 167
Hawkins, C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.17.1861 · Cited by 166
Ruhe, J. J., Monson, T., Bradsher, R. W., & Menon, A. (2005) · Clinical Infectious Diseases · doi:10.1086/429628 · Cited by 166
Drew, R. H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.775 · Cited by 165
Schmitz, G. R., Bruner, D., Pitotti, R., Olderog, C., Livengood, T., Williams, J., Huebner, K., Lightfoot, J., Ritz, B., Bates, C., et al. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.03.002 · Cited by 164
Bacteremic Staphylococcus aureus Spondylitis
Jensen, A. G., Espersen, F., Skinhøj, P., & Frimodt-Møller, N. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.5.509 · Cited by 164
Young, D. M. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.9.947 · Cited by 162
Clindamycin-Induced Suppression of Toxic-Shock Syndrome-Associated Exotoxin Production
Schlievert, P. M., & Kelly, J. A. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.3.471 · Cited by 162
Maor, Y., Hagin, M., Belausov, N., Keller, N., Ben-David, D., & Rahav, G. (2009) · Journal of Infectious Diseases · doi:10.1086/596629 · Cited by 162
Bhatia, K., & Jones, N. S. (2002) · The Journal of Laryngology & Otology · doi:10.1258/002221502760237920 · Cited by 156
Pfausler, B., Spiss, H., Beer, R., Kampfl, A., Engelhardt, K. W., Schober, M., & Schmutzhard, E. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.5.1040 · Cited by 155
Albanèse, J., Léone, M., Bruguerolle, B., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1356-1358.2000 · Cited by 155
Darenberg, J., Söderquist, B., Normark, B. H., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381979 · Cited by 154
Staphylococcus aureus Prosthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B. (1998) · Clinical Infectious Diseases · doi:10.1086/516378 · Cited by 153
Self-citationFigueroa, D. A., Mangini, E., Amodio-Groton, M. I., Vardianos, B., MELCHERT, A., Fana, C., Wehbeh, W., Urban, C. M., & Segal‐Maurer, S. (2009) · Clinical Infectious Diseases · doi:10.1086/600039 · Cited by 153
The Role of β-Hemolytic Streptococci in Causing Diffuse, Nonculturable Cellulitis
Jeng, A., Beheshti, M., Li, J., & Nathan, R. V. (2010) · Medicine · doi:10.1097/md.0b013e3181e8d635 · Cited by 151
(1990) · Infectious Diseases Newsletter · doi:10.1016/0278-2316(90)90059-o · Cited by 151
Stein, A., Bataille, J. F., Drancourt, M., Curvale, G., Argenson, J., Groulier, P., & Raoult, D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3086 · Cited by 150
Moore, M. R., Perdreau‐Remington, F., & Chambers, H. F. “. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1262-1266.2003 · Cited by 149
Self-citationShort-Course Therapy of Catheter-related Staphylococcus aureus Bacteremia
Jernigan, J. A., & Farr, B. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00010 · Cited by 147
Frymoyer, A. R., Hersh, A. L., Benet, L. Z., & Guglielmo, B. J. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181906e40 · Cited by 146
Vancomycin concentrations in infected and noninfected human bone
Graziani, A. L., Lawson, L. A., Gibson, G. A., et al. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1320 · Cited by 145
Han, L. L., McDougal, L. K., Gorwitz, R. J., Mayer, K. H., Patel, J. B., Sennott, J. M., & Fontana, J. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02274-06 · Cited by 144
Self-citationJames, J. K., Palmer, S. M., Levine, D. P., & Rybak, M. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.696 · Cited by 143
Self-citationAntoniou, T. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.142 · Cited by 140
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Goldstein, E. J. C., & Proctor, R. A. (2008) · Clinical Infectious Diseases · doi:10.1086/525536 · Cited by 138
Riedel, D. J., Weekes, E., & Forrest, G. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00300-08 · Cited by 136
Jacqueline, C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg160 · Cited by 134
Sakoulas, G., Eliopoulos, G. M., Alder, J. D., & Eliopoulos, C. T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1714-1718.2003 · Cited by 133
Polyclonal Immunoglobulin for Treatment of Bacterial Sepsis: A Systematic Review
Pildal, J., & Gøtzsche, P. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421089 · Cited by 131
Yang, S., Xiong, Y. Q., Boyle‐Vavra, S., Daum, R., Jones, T., & Bayer, A. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00487-10 · Cited by 130
Self-citationEllis, M. W., Griffith, M. E., Dooley, D. P., McLean, J. C., Jorgensen, J. H., PATTERSON, J. E., Davis, K. A., Hawley, J. S., Regules, J. A., Rivard, R. G., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01086-06 · Cited by 129
Mupirocin Prophylaxis against Nosocomial Staphylococcus aureus Infections in Nonsurgical Patients
Wertheim, H. F. L., Vos, M. D., Ott, A., Voß, A., Kluytmans, J. A. J. W., Vandenbroucke‐Grauls, C. M. J. E., Meester, M. H. M., van Keulen, P. H. J., & Verbrugh, H. A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00007 · Cited by 127
Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Rémadi, J. P., Habib, G., Nadji, G., Brahim, A., Thuny, F., Casalta, J., Peltier, M., & Tribouilloy, C. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.09.093 · Cited by 127
Trimethoprim-Sulfamethoxazole for Bacterial Meningitis
Levitz, R. E., & QUINTILIANI, R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-881 · Cited by 126
Hultén, K. G., Kaplan, S. L., Gonzalez, B. E., Hammerman, W. A., Lamberth, L. B., Versalovic, J. A., & Mason, E. O. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000207404.50143.1e · Cited by 125
Self-citationChavez-Bueno, S., Bozdogan, B., Katz, K., Bowlware, K. L., Cushion, N., Cavuoti, D., Ahmad, N., McCracken, G. H., & Appelbaum, P. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2283-2288.2005 · Cited by 124
Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses
Forouzesh, A., Moise, P. A., & Sakoulas, G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01088-08 · Cited by 124
Prakash, V., Lewis, J. S., & Jorgensen, J. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00904-08 · Cited by 123
Zahar, J., Clec’h, C., Tafflet, M., Garrouste-Orgeas, M., Jamali, S., Mourvillier, B., de Lassence, A., Descorps-Declere, A., Adrie, C., de Beauregard, M. A. C., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496923 · Cited by 123
Swenson, J. M., Anderson, K. F., Lonsway, D. R., Thompson, A. D., McAllister, S. K., Limbago, B. M., Carey, R. B., Tenover, F. C., & Patel, J. B. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00221-09 · Cited by 123
Wootton, M., MacGowan, A. P., Walsh, T. R., & Howe, R. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01508-06 · Cited by 123
Ruhe, J., & Menon, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-07 · Cited by 122
Abraham, J. M., Mansour, C., Veledar, E., Khan, B. V., & Lerakis, S. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.09.018 · Cited by 121
Sader, H. S., Fey, P. D., Fish, D. N., Limaye, A. P., Pankey, G. A., Rahal, J. J., Rybak, M. J., Snydman, D. R., Steed, L. L., Waites, K. B., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00616-09 · Cited by 121
Self-citation
Research works printed but not linked: 62
- Centers for Disease Control and Prevention, 2007, Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza–Louisiana Georgia, December 2006-January 2007, MMWR Morb Mortal Wkly Rep, 56, 325
- 1979, Canadian Task Force on the Periodic Health Examination, Can Med Assoc J, 121, 1193
- Nicholas, 1975, Concentration of clindamycin in human bone, Antimicrob Agents Chemother, 8, 220, 10.1128/AAC.8.2.220 · doi:10.1128/aac.8.2.220
- Joiner, 1981, Antibiotic levels in infected and sterile subcutaneous abscesses in mice, J Infect Dis, 143, 487, 10.1093/infdis/143.3.487 · doi:10.1093/infdis/143.3.487
- Panzer, 1972, Clindamycin levels in various body tissues and fluids, J Clin Pharmacol New Drugs, 12, 259, 10.1002/j.1552-4604.1972.tb00052.x · doi:10.1002/j.1552-4604.1972.tb00052.x
- Miller, 2010, Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases, Clin Infect Dis, 50, e63, 10.1086/652656 · doi:10.1086/652656
- Abdel-Rahman, 2008, Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections, Pediatr Infect Dis J, 27, 330, 10.1097/INF.0b013e318160edfc · doi:10.1097/inf.0b013e318160edfc
- Loeffler, 2002, Safety and efficacy of quinupristin/dalfopristin for treatment of invasive gram-positive infections in pediatric patients, Pediatr Infect Dis J, 21, 950, 10.1097/00006454-200210000-00013 · doi:10.1097/00006454-200210000-00013
- Norden, 1986, Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy, South Med J, 79, 947, 10.1097/00007611-198608000-00008 · doi:10.1097/00007611-198608000-00008
- Saravolatz, 2009, Telavancin: a novel lipoglycopeptide, Clin Infect Dis, 49, 1908, 10.1086/648438 · doi:10.1086/648438
- Sanchez, 1997, Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection, Enferm Infecc Microbiol Clin, 15, 10
- Cooper, 1986, Pharmacokinetics of vancomycin. Vancomycin: a comprehensive review of 30 years clinical experience, 23
- d'Oliveira, 2003, Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil, Microb Drug Resist, 9, 87, 10.1089/107662903764736382 · doi:10.1089/107662903764736382
- Libertin, 1983, Effects of trimethoprim-sulfamethoxazole and incubation atmosphere on isolation of group A streptococci, J Clin Microbiol, 18, 680, 10.1128/JCM.18.3.680-682.1983 · doi:10.1128/jcm.18.3.680-682.1983
- Trickett, 1973, Clinical experience: respiratory tract. Trimethoprim-sulfamethoxazole versus penicillin G in the treatment of group A beta-hemolytic streptococcal pharyngitis tonsillitis, J Infect Dis, 128, 693, 10.1093/infdis/128.Supplement_3.S693 · doi:10.1093/infdis/128.supplement_3.s693
- Tayal, 2006, The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department, Acad Emerg Med, 13, 384, 10.1197/j.aem.2005.11.074 · doi:10.1197/j.aem.2005.11.074
- Squire, 2005, ABSCESS: applied bedside sonography for convenient evaluation of superficial soft tissue infections, Acad Emerg Med, 12, 601, 10.1197/j.aem.2005.01.016 · doi:10.1197/j.aem.2005.01.016
- Fleisher, 1980, Cellulitis: a prospective study, Ann Emerg Med, 9, 246, 10.1016/S0196-0644(80)80380-5 · doi:10.1016/s0196-0644(80)80380-5
- Fleisher, 1980, Cellulitis: bacterial etiology, clinical features, and laboratory findings, J Pediatr, 97, 591, 10.1016/S0022-3476(80)80014-X · doi:10.1016/s0022-3476(80)80014-x
- Newell, 1988, Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults, J Clin Microbiol, 26, 401, 10.1128/JCM.26.3.401-404.1988 · doi:10.1128/jcm.26.3.401-404.1988
- Centers for Disease Control Prevention, Environmental cleaning & disinfecting for MRSA: what's the difference between cleaners, sanitizers, and disinfectants? 2010
- American Academy of Pediatrics, Antibacterial Drugs for Newborn Infantsl
- Wendt, 2007, Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial, Infect Control Hosp Epidemiol, 28, 1036, 10.1086/519929 · doi:10.1086/519929
- Washington University School of Medicine, Staphylococcus aureus decolonization study (SuDS) (NCT00731783)
- Natividad Medical Center, A prospective trial of nasal mupirocin, hexachlorophene body Wash, systemic antibiotics for prevention of recurrent methicillin resistant staphylococcus aureus infections (NCT01049438)
- Los Angeles Biomedical Research Institute, A randomized clinical trial to prevent recurrent CA-MRSA infection (PRIMO) (NCT00560599)
- Chandorkar, 2009, Pharmacokinetics (PK) and safety of 8 and 10 mg/kg of daptomycin in pediatric patients aged 2 to 6 years. [abstract number 1243]
- Boucher, 2006, Appropriateness of two-week therapy for catheter-related S. aureus bacteremia [abstract number L-1204]
- Conte, 2002, Intrapulmonary pharmacokinetics of linezolid, Antimicrob Agents Chemother, 46, 1475, 10.1128/AAC.46.5.1475-1480.2002 · doi:10.1128/aac.46.5.1475-1480.2002
- Daver, 2007, Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis, J Infect, 54, 539, 10.1016/j.jinf.2006.11.011 · doi:10.1016/j.jinf.2006.11.011
- Al-Nammari, 2007, Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis, Spine (Phila Pa 1976), 32, 2480, 10.1097/BRS.0b013e318157393e · doi:10.1097/brs.0b013e318157393e
- Van der Auwera, 1985, Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections, Antimicrob Agents Chemother, 28, 467, 10.1128/AAC.28.4.467 · doi:10.1128/aac.28.4.467
- Priest, 2005, Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes, South Med J, 98, 854, 10.1097/01.smj.0000168666.98129.33 · doi:10.1097/01.smj.0000168666.98129.33
- Crompton, 2009, Safety and efficacy of daptomycin in the treatment of osteomyelitis: results from the CORE Registry, J Chemother, 21, 414, 10.1179/joc.2009.21.4.414 · doi:10.1179/joc.2009.21.4.414
- Shipton, 2007, Experience with daptomycin in Staphylococcus bone and joint infections: case series and emergence of nonsusceptibility, Infect Dis Clin Pract, 15, 324, 10.1097/IPC.0b013e318142cbbf · doi:10.1097/ipc.0b013e318142cbbf
- Chen, 2007, Experience with linezolid therapy in children with osteoarticular infections, Pediatr Infect Dis J, 26, 985, 10.1097/INF.0b013e31812e62dc · doi:10.1097/inf.0b013e31812e62dc
- Rao, 2007, Efficacy and safety of linezolid for gram-positive orthopedic infections: a prospective case series, Diagn Microbiol Infect Dis, 59, 173, 10.1016/j.diagmicrobio.2007.04.006 · doi:10.1016/j.diagmicrobio.2007.04.006
- Simpson, 2001, Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival, J Bone Joint Surg Br, 83, 403, 10.1302/0301-620X.83B3.0830403 · doi:10.1302/0301-620x.83b3.0830403
- Aboltins, 2007, Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid, Clin Microbiol Infect, 13, 586, 10.1111/j.1469-0691.2007.01691.x · doi:10.1111/j.1469-0691.2007.01691.x
- Zalavras, 2009, Infection following operative treatment of ankle fractures, Clin Orthop Relat Res, 467, 1715, 10.1007/s11999-009-0743-8 · doi:10.1007/s11999-009-0743-8
- Ballock, 2009, A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis, J Pediatr Orthop, 29, 636, 10.1097/BPO.0b013e3181b2b860 · doi:10.1097/bpo.0b013e3181b2b860
- Jorgenson, 2007, Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices, Pediatr Neurosurg, 43, 449, 10.1159/000108786 · doi:10.1159/000108786
- Myrianthefs, 2006, Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients, Antimicrob Agents Chemother, 50, 3971, 10.1128/AAC.00051-06 · doi:10.1128/aac.00051-06
- Beer, 2007, Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains, Antimicrob Agents Chemother, 51, 379, 10.1128/AAC.00515-06 · doi:10.1128/aac.00515-06
- Nagashima, 2008, Effect of linezolid against postneurosurgical meningitis caused by methicillin-resistant Staphylococcus epidermidis: case report, J Infect Chemother, 14, 147, 10.1007/s10156-007-0582-Z · doi:10.1007/s10156-007-0582-z
- Ntziora, 2007, Linezolid for the treatment of patients with central nervous system infection, Ann Pharmacother, 41, 296, 10.1345/aph.1H307 · doi:10.1345/aph.1h307
- Vartzelis, 2005, Brain abscesses complicating Staphylococcus aureus sepsis in a premature infant, Infection, 33, 36, 10.1007/s15010-005-4062-z · doi:10.1007/s15010-005-4062-z
- Schreffler, 2002, Treatment of cerebrospinal fluid shunt infections: a decision analysis, Pediatr Infect Dis J, 21, 632, 10.1097/00006454-200207000-00006 · doi:10.1097/00006454-200207000-00006
- Whitehead, 2001, The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons, Pediatr Neurosurg, 35, 205, 10.1159/000050422 · doi:10.1159/000050422
- Sacar, 2006, A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period, BMC Infect Dis, 6, 43, 10.1186/1471-2334-6-43 · doi:10.1186/1471-2334-6-43
- Elvy, 2008, Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin, J Antimicrob Chemother, 61, 461, 10.1093/jac/dkm501 · doi:10.1093/jac/dkm501
- Ho, 1986, In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus, Diagn Microbiol Infect Dis, 4, 133, 10.1016/0732-8893(86)90147-1 · doi:10.1016/0732-8893(86)90147-1
- Yanagisawa, 2007, Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin, J Infect Chemother, 13, 368, 10.1007/s10156-007-0551-6 · doi:10.1007/s10156-007-0551-6
- Ebert, 1987, In vivo cidal activity and pharmacokinetic parameters for vancomycin against methicillin-susceptible and resistant S. aureus [abstract 439]
- Dudley, 1999, Pharmacokinetic-pharmacodynamic indices for vancomycin treatment of susceptible intermediate S. aureus in the neutropenic murine thigh model [abstract 2031]
- Moise, 2000, Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus, Am J Health Syst Pharm, 57, S4, 10.1093/ajhp/57.suppl_2.S4 · doi:10.1093/ajhp/57.suppl_2.s4
- Lee-Such, 2006, Nephrotoxicity associated with aggressive vancomycin therapy [abstract #1298]
- Odio, 1984, Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children, J Pediatr, 105, 491, 10.1016/S0022-3476(84)80036-0 · doi:10.1016/s0022-3476(84)80036-0
- Kullar, 2009, High-dose daptomycin for complicated gram-positive infections [poster # 1984]
- Gebhart, 2007, Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid rifampin, Pharmacotherapy, 27, 476, 10.1592/phco.27.3.476 · doi:10.1592/phco.27.3.476
- Tan, 1993, Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia, Antimicrob Agents Chemother, 37, 2401, 10.1128/AAC.37.11.2401 · doi:10.1128/aac.37.11.2401
- Deville, 2003, Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates, Pediatr Infect Dis J, 22, S158, 10.1097/01.inf.0000086955.93702.c7 · doi:10.1097/01.inf.0000086955.93702.c7
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Metadata
- Authors
- Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., Rybak, M. J., Talan, D. A., & Chambers, H. F.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-01
- Volume
- 52
- Issue
- 3
- Pages
- e18-e55
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108433768
- Cited by
- 4,191
- References
- 317
- FWCI
- 199.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.